-
IHH Healthcare (SGX:Q0F)'s 1Q26 earnings met our expectations but missed consensus. Softness in Singapore persisted, but this was more than offset by Turkiye and Malaysia.
Within our expectations, but disappointed consensus.
- - Read this at SGinvestors.io -
-
Turkiye operations were a standout as the softness in Singapore was offset by Malaysia.
Singapore drags, Malaysia shields.
-
Top-line of its Singapore operations contracted sharply (-12.0%) due a structural shift in local patients opting for higher public healthcare utilisation and fewer Indonesian patients due to the depreciating rupiah. Inpatient admission declined 7.5% y-o-y amid easing revenue intensity (-3.5% y-o-y). This culminated in operational earnings contracting sharply by 18.1% y-o-y.
- - Read this at SGinvestors.io -
Acibadem continues to deliver.
- Read more at SGinvestors.io.
Above is an excerpt from a report by UOB Kay Hian Research.
Clients of UOB Kay Hian may be the first to access the full PDF report @ https://www.utrade.com.sg/.
Philip Wong UOB Kay Hian Research | https://research.uobkayhian.com/ 2026-05-28
Previous report by UOB:
2025-10-21 IHH Healthcare - Defensive Medicine In a Risk-On Market.
Price targets by 3 other brokers at IHH Healthcare Target Prices.
Listing of research reports at IHH Healthcare Analyst Reports.
Relevant links:
IHH Healthcare Share Price History,
IHH Healthcare Announcements,
IHH Healthcare Dividend Payout Dates & Corporate Actions,
IHH Healthcare News
